CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, D.
Right arrow Articles by Hurst, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, D.
Right arrow Articles by Hurst, T.

Canadian Journal of Anesthesia, Vol 37, 287-295, Copyright © 1990 by Canadian Anesthesiologists' Society


ARTICLES

Halothane inhibits hypoxic pulmonary vasoconstriction in the presence of cyclooxygenase blockade

D Johnson, I Mayers and T Hurst
Department of Anaesthesia, University Hospital, University of Saskatchewan, Saskatoon, Canada.

Using an isolated lung the effects of halothane on hypoxic pulmonary vasoconstriction (HPV) were studied in the presence of cyclooxygenase blockade. The pulmonary vasculature can be divided into arterial, middle and venous segment resistances. Analysis of the vascular pressure-flow relationship further separates resistance into a flow dependent resistance (1/slope) and a zero-flow pressure intercept (PCRIT). We ventilated six lobes with control (35 per cent O2) and hypoxic (three per cent O2) gas mixtures with the addition of either 0, 0.5, 1.0, or 2.0 per cent halothane. We found that after addition of indomethacin (5 mg.kg-1), ventilation with three per cent O2 increased total resistance by 87 per cent over baseline with the increase primarily in the middle vascular segment. During normoxic ventilation PCRIT was 7.9 cm H2O and this increased significantly with hypoxia to 11.5 cm H2O). Only 2.0 per cent halothane blocked the increases in middle segment resistance and in PCRIT. We conclude that following cyclooxygenase blockade, halothane inhibits HPV by acting on middle segment vessels.


This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
M. L. Fisher and S. C. Body
Physiology of One-Lung Ventilation
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1997; 1(3): 236 - 255.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Johnson, D. Thomson, T. Hurst, K. Prasad, T. Wilson, F. Murphy, A. Saxena, and I. Mayers
Neutrophil-mediated acute lung injury after extracorporeal perfusion
J. Thorac. Cardiovasc. Surg., May 1, 1994; 107(5): 1193 - 1202.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the Canadian Anesthesiologists' Society.